BPC 157 & TB 500 (5/5mg) Blend

BPC-157 TB-500 5/5mg catalog details

BPC-157 TB-500 5/5mg is the smaller two-component blend listed by USA Eternal Peptides. Its name specifies 5mg for each named component. The individual vial pages and the 10/10mg blend describe different catalog records, with their own quantities and documentation.

Documentation for BPC-157 TB-500 5/5mg

Open the product COA images to inspect the original issuer, tested sample and batch details. The Eternal Peptides COA library provides a broader document index. These recovered reports concern historical source samples and do not certify a new lot supplied by USA Eternal Peptides.

Distinguish each component amount from total blend mass

The 5/5mg designation lists two amounts rather than a single-compound quantity. Record both names and both numbers together. The combination should not be mislabeled as an individual BPC-157 5mg or an individual TB-500 5mg product.

Compare the smaller and larger combined entries

The 10/10mg blend lists a different quantity for each component. Compare the product identity and any relevant tested-sample details before making a selection. A lower or higher pack mass does not by itself establish purity, potency or clinical suitability.

What is BPC 157 + TB 500 Blend?

The BPC 157 + TB 500 blend, also known as the Wolverine blend, combines two synthetic research peptides: BPC-157 and TB-500. BPC-157 is a stable pentadecapeptide originally identified as part of a gastric protein complex, while TB-500 is a synthetic fragment of thymosin beta-4 comprising the active actin-binding domain.

Both peptides have been extensively studied in preclinical settings for their roles in cellular repair processes, angiogenesis, and modulation of inflammatory pathways.

In current research, this blend is being investigated for its potential synergistic effects on tissue healing, including tendon, muscle, and soft-tissue recovery, as well as vascular stabilization and cytoprotective mechanisms.

That’s because BPC-157 is associated with endothelial signalling and growth-factor modulation, while TB-500 is studied for its interactions with actin dynamics and cell migration. Together, they are often explored for complementary contributions to tissue regeneration models.

Note that most findings come primarily from in vitro experiments and animal studies, with minimal controlled human research available. BPC-157 and TB-500 are not approved for any form of human or animal clinical or therapeutic applications.

How BPC-157 + TB-500 Blend Works (Mechanism of Action)

According to research and recent studies, the BPC-157 + TB-500 Blend appears to act through multiple coordinated biological pathways, reflecting the pleiotropic nature of both peptides. 

Mechanistic insights derived predominantly from in vitro and animal studies explore their roles in cellular repair, angiogenesis, inflammation modulation, and cytoprotection. While the two peptides act independently, their combined use in research models is thought to produce complementary or additive effects on tissue recovery processes.

Angiogenesis and Endothelial Support

Preclinical research suggests that BPC-157 may influence angiogenic pathways, particularly those associated with endothelial stability and microvascular repair[1].

These effects are commonly linked to modulation of growth-factor signalling and endothelial nitric-oxide synthase activity. TB-500, through its interaction with actin dynamics, has also been studied for its potential role in promoting vascular remodeling and supporting the formation of new microvessels[2].

Together, these actions may enhance blood flow and nutrient delivery to injured tissues, a key factor in effective tissue repair. Improved microcirculation can support the survival of damaged cells, maintain oxygen delivery, and promote the restoration of functional tissue architecture.

Actin Dynamics, Cell Migration, and Tissue Remodeling

TB-500 is a synthetic fragment of thymosin beta-4, a peptide known for regulating actin polymerization and influencing the movement of cells during repair processes[2]. Studies suggest that TB-500 can support cytoskeletal organization, cell migration, and extracellular-matrix remodeling[3]. 

BPC-157 has also been investigated for its potential interactions with adhesion-related proteins such as FAK and paxillin, which contribute to cellular migration and tissue restoration[4].

In combination, these peptides may help accelerate the movement of repair cells to injury sites and support the structural restoration of tissues. These processes are fundamental to the healing of muscle, tendon, and connective tissue in experimental models.

Inflammatory Modulation and Cytoprotective Activity

Preclinical models indicate that both BPC-157 and TB-500 exert regulatory influence over inflammatory pathways. BPC-157 has been associated with balanced nitric-oxide signalling and attenuation of excessive inflammatory responses[5], while TB-500 has been studied for its potential to reduce pro-inflammatory mediators and support protective cellular environments[6].

By helping to control excessive inflammation, the blend may reduce secondary tissue damage and support a more favorable environment for healing. This type of modulation is often critical in preventing prolonged inflammation that can impair recovery or lead to fibrosis in research models.

Gastrointestinal and Organ Protection Findings

BPC-157 has been extensively studied for its effects on gastrointestinal tissues, including protection of the mucosal lining, modulation of lesion formation, and support of barrier integrity in rodent models[7]. 

Similarly, TB-500 has been explored in organ-protection contexts as well, with studies examining its influence on cellular survival under stress conditions[2].

These findings suggest that the blend may offer a broad spectrum of cytoprotective activity across multiple tissue types in experimental settings. Enhanced resilience of organ tissues under stress can be an important factor in complex injury models, though these effects remain limited to preclinical observations.

BPC157 + TB500 Blend (Wolverine Blend)

Molecular Formula: C62H98N16O22(BPC-157) & C212H350N56O78S(TB-500)

Batch: EP-250414-BT05

BPC-157 + TB-500 Blend: Handling & Storage Guidelines

Once your order arrives, store the lyophilized BPC-157 + TB-500 Blend at –4 °F (–20 °C), protected from light and moisture, to maintain peptide stability prior to use. Keep vials tightly sealed until reconstitution.

During preparation, reconstitute the lyophilized powder using bacteriostatic water or other approved laboratory-grade solvents appropriate for the intended assay. Gently swirl or invert to dissolve; avoid vigorous shaking, which may degrade peptide structure.

Buy bacteriostatic water right here on USA Eternal Peptides for best results.

After reconstitution, aliquot the solution into appropriately sized volumes to minimize repeated freeze–thaw cycles as it can reduce peptide integrity and experimental consistency.

Aliquoted working solutions may be stored short term at 39.2 °F (4 °C) when required by protocol, while longer-term storage should be at –112 °F to –4 °F (–80 °C to –20 °C), depending on institutional standards and experimental design.

All handling should follow standard laboratory biosafety practices, institutional operating procedures, and applicable chemical-handling and research-use regulations.

Certificates of Analysis and Quality Assurance

Every lot of the BPC 157 + TB 500 Blend from USA Eternal Peptides is accompanied by a Certificate of Analysis (COA) to support transparency, traceability, and reproducible research outcomes. COAs are issued on a per-lot basis and are directly linked to the specific batch received, allowing researchers to verify material consistency across experiments.

Each COA typically documents peptide identity confirmed by analytical methods such as high-performance liquid chromatography (HPLC) and/or mass spectrometry, along with quantitative purity results, which are generally ≥99%. Where applicable, reports may also include sterility testing, endotoxin levels, and additional quality parameters relevant to laboratory use, as well as lot-specific storage and handling recommendations.

USA Eternal Peptides partners with independent, industry-recognized third-party testing laboratories, including Janoshik, to ensure objective and reliable quality verification. All COAs are publicly accessible through the USA Eternal Peptides Lab Tests page, supporting internal audits, regulatory documentation, and experimental reproducibility in research settings.

Legal / Regulatory Disclaimer

The BPC-157 + TB-500 Blend offered by USA Eternal Peptides is supplied strictly for laboratory research use only. This product is not approved for human or veterinary use and is not intended for clinical administration, therapeutic treatment, or diagnostic procedures. The safety, efficacy, and pharmacological profile of this compound in humans have not been established.

You as the purchasers/users are solely responsible for ensuring compliance with all applicable local, national, and international laws, as well as institutional biosafety guidelines and research-use regulations. Any misrepresentation of intended use or misuse of this product may result in regulatory action or legal consequences.

Scientific References

1. Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals, 18(2), 185.

https://www.mdpi.com/1424-8247/18/2/185 

2. Maar K, Hetenyi R, Maar S, Faskerti G, Hanna D, Lippai B, Takatsy A, Bock-Marquette I. Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. Cells. 2021 May 28;10(6):1343.

https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050/ 

3. Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol. 2007 Sep;1(3):201-7. PMID: 19668473; PMCID: PMC2701135.

https://pmc.ncbi.nlm.nih.gov/articles/PMC2701135/ 

4. Chung-Hsun Chang, Wen-Chung Tsai, Miao-Sui Lin, Ya-Hui Hsu, and Jong-Hwei Su Pang. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology 2011 110:3, 774-780.

https://journals.physiology.org/doi/full/10.1152/japplphysiol.00945.2010

5. McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025 Dec;18(12):611-619.

https://pmc.ncbi.nlm.nih.gov/articles/PMC12446177/ 

6. Maar K, Hetenyi R, Maar S, Faskerti G, Hanna D, Lippai B, Takatsy A, Bock-Marquette I. Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. Cells. 2021 May 28;10(6):1343.

https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050/ 

7. Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic J. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865.

https://pmc.ncbi.nlm.nih.gov/articles/PMC5333585/ 

Is 5/5mg a single 5mg compound listing?

No. The title lists two named components with separate quantities. It is a different catalog entry from either individual 5mg vial.

Catalog comparisons for this product

Compare the separately identified records for BPC-157 TB-500 10/10mg, BPC-157 5mg, TB-500 5mg. Each link leads to its own named product and quantity; it does not recommend combining or substituting materials.

The selected BPC-157 TB-500 5/5mg quantity, current price and availability appear in this product record. Review shipping and returns information and payment options before submitting an order. Listed amounts are pack quantities, not dosing instructions. All materials are for laboratory research only, not for human or animal consumption.

Original Eternal Peptides reports retain their tested supplier and batch identity. USA Eternal Peptides is independent; these reports do not certify its inventory.